Susan X Lin1, E Xavier Pi-Sunyer. 1. Columbia University School of Nursing, New York, New York, USA. XL18@columbia.edu
Abstract
OBJECTIVE: This study examined the racial differences in the distribution of the individual and clustered metabolic syndrome components among diabetics and nondiabetics and the presence of inflammatory markers. STUDY DESIGN AND METHOD: This is a secondary data analysis of the National Health and Nutrition Examination Survey (NHANES) from 1999-2002. The analysis only included adults aged > or = 40 years who were White, Black, and Mexican American. Differences in the rate of metabolic syndrome, each of its components, and inflammation markers among the three racial groups were examined by using chi-square tests. RESULTS: An estimated 12 million adults > or = 40 years of age have diagnosed and undiagnosed diabetes. Most diabetics have metabolic syndrome (69.9% for Whites, 64.8% for Blacks, and 62.4% for Mexican Americans). Abdominal obesity is more prevalent among Whites with diabetes than Mexican Americans (80.6% vs 67.8%, P = .008). Hypertension is significantly greater among Blacks with diabetes (73.1%) as compared to Whites (58.6%) and Mexican Americans (50.8%); hypertension in those without diabetes was 47.5% among Blacks, 32.4% among Whites, and 23.4% among Mexican Americans. Among nondiabetics, Blacks have higher prevalence of elevated serum C-reactive protein (17.4%) and high plasma fibrinogen (49.7%) than Whites (9.7% and 36%, respectively). CONCLUSION: These data demonstrate racial differences in the prevalence of components of the metabolic syndrome among diabetics and nondiabetics. They raise questions about the current definition of the metabolic syndrome, which weights each component equally. Further research is necessary to more precisely quantify the characteristics of metabolic syndrome in different racial and ethnic groups.
OBJECTIVE: This study examined the racial differences in the distribution of the individual and clustered metabolic syndrome components among diabetics and nondiabetics and the presence of inflammatory markers. STUDY DESIGN AND METHOD: This is a secondary data analysis of the National Health and Nutrition Examination Survey (NHANES) from 1999-2002. The analysis only included adults aged > or = 40 years who were White, Black, and Mexican American. Differences in the rate of metabolic syndrome, each of its components, and inflammation markers among the three racial groups were examined by using chi-square tests. RESULTS: An estimated 12 million adults > or = 40 years of age have diagnosed and undiagnosed diabetes. Most diabetics have metabolic syndrome (69.9% for Whites, 64.8% for Blacks, and 62.4% for Mexican Americans). Abdominal obesity is more prevalent among Whites with diabetes than Mexican Americans (80.6% vs 67.8%, P = .008). Hypertension is significantly greater among Blacks with diabetes (73.1%) as compared to Whites (58.6%) and Mexican Americans (50.8%); hypertension in those without diabetes was 47.5% among Blacks, 32.4% among Whites, and 23.4% among Mexican Americans. Among nondiabetics, Blacks have higher prevalence of elevated serum C-reactive protein (17.4%) and high plasma fibrinogen (49.7%) than Whites (9.7% and 36%, respectively). CONCLUSION: These data demonstrate racial differences in the prevalence of components of the metabolic syndrome among diabetics and nondiabetics. They raise questions about the current definition of the metabolic syndrome, which weights each component equally. Further research is necessary to more precisely quantify the characteristics of metabolic syndrome in different racial and ethnic groups.
Authors: Alexandra D Ogorodnikova; Mimi Kim; Aileen P McGinn; Paul Muntner; Unab Khan; Rachel P Wildman Journal: Obesity (Silver Spring) Date: 2011-07-28 Impact factor: 5.002
Authors: Erica Rosenberger Hale; David C Goff; Scott Isom; Caroline Blackwell; Melicia C Whitt-Glover; Jeffery A Katula Journal: J Phys Act Health Date: 2012-10-04
Authors: Karla Espinosa de Los Monteros; Linda C Gallo; John P Elder; Gregory A Talavera Journal: Am J Public Health Date: 2008-09-17 Impact factor: 9.308
Authors: Shahryar M Chowdhury; Melissa H Henshaw; Brad Friedman; J Philip Saul; Girish S Shirali; Janet Carter; Bryana M Levitan; Tom Hulsey Journal: J Am Soc Echocardiogr Date: 2014-02-08 Impact factor: 5.251
Authors: Nicoleta D Sora; Nicole M Marlow; Dipankar Bandyopadhyay; Renata S Leite; Elizabeth H Slate; Jyotika K Fernandes Journal: J Clin Periodontol Date: 2013-04-05 Impact factor: 8.728
Authors: Charles E Matthews; Xuemei Sui; Michael J LaMonte; Swann A Adams; James R Hébert; Steven N Blair Journal: Metabolism Date: 2010-01-04 Impact factor: 8.694
Authors: Erdembileg Anuurad; Jill Rubin; Alan Chiem; Russell P Tracy; Thomas A Pearson; Lars Berglund Journal: J Clin Endocrinol Metab Date: 2008-02-05 Impact factor: 5.958
Authors: Lillian Gleiberman; Tiffany A Greenwood; Amy Luke; Maria C Delgado; Alan B Weder Journal: J Clin Hypertens (Greenwich) Date: 2008-09 Impact factor: 3.738